Monday, August 24, 2020

Lupin gets USFDA nod for asthmatic symptoms prevention drug

Lupin gets USFDA nod for asthmatic symptoms prevention drug In a regulatory filing, Lupin said it has received approval from the United States Food and Drug Administration (USFDA) for its Albuterol Sulfate Inhalation Aerosol, 90 mcg (base)/actuation.

from Moneycontrol Business News https://ift.tt/34tFTD8

No comments:

Post a Comment

FII exodus deepens in 2026 at Rs 1.75 lakh crore as April outflows swell to Rs 43,967 crore; FOMC next trigger

Foreign institutional investors offloaded Indian equities worth Rs 17,140 crore last week, extending April's outflows to Rs 43,967 crore...